CrowdStrike Holdings has room to run as Anthropic's rollout of its latest artificial intelligence model seems to fuel interest in AI-powered cybersecurity solutions, according to Wolfe Research. The ...
Argan’s post-earnings 38% surge highlights how strong earnings visibility can drive outsized gains despite macro uncertainty.
Q32 Bio is now largely a single-asset story centered on Bempikibart in alopecia areata, with mid-2026 topline data as the key catalyst. See why QTTB stock is a Buy.